Status:
RECRUITING
Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage
Lead Sponsor:
Fenghui Deng
Conditions:
Herpes Zoster (HZ)
Eligibility:
All Genders
40-85 years
Phase:
PHASE2
Brief Summary
Participants will be invited to take part in clinical research. This informed consent form will provide information to the participants to help them decide whether to participate in the clinical study...
Eligibility Criteria
Inclusion
- Patients with adverse reactions that are not effective in conventional drug treatment and cannot tolerate drugs
- The pain is located in the corresponding innervated are
- The pain affects the patient's daily life or work
- Diagnostic nerve block is effective and pain limited
- Recurrent herpes zoster pain
- Patients with shingle-related pain aged 40-85 years
Exclusion
- Infection at the puncture site, systemic infection that may spread, and malignant tumors near the puncture
- There are contraindications in minimally invasive interventional therapy such as coagulation function and platelet dysfunction
- Allergies to local anesthetics and inhalants
- Heart, lung, liver, kidney and other important organ failure, can not tolerate surgery
- Severe endocrine system diseases or long-term use of hormone or immunosuppressive therapy
- Patients with cardiac pacemakers, pregnant or lactating women
- Patients with cognitive dysfunction or poor coordination
- Patients who have been treated with electrical stimulation or PRF
Key Trial Info
Start Date :
December 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT06978192
Start Date
December 16 2024
End Date
May 31 2026
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Affiliated Hospital of Zunyi Medical University
Zunyi, Guizhou, China, 563000